Learning and knowledge sharing are fundamental to the LHSS Project. We invite you to search LHSS knowledge products and resources for the latest approaches, insights, and learning in the field of integrated health systems strengthening.
Clients at an HIV clinic in Vietnam are finally having their viral load tests reimbursed, thanks to some multisectoral problem-solving facilitated by LHSS.
An estimated 170,000 people contract TB each year in Vietnam. The new e-LMIS system helps ensure a reliable drug supply for those who need treatment.
In this webinar, we share best practices and learn how these efforts have helped to improve equitable access to care for vulnerable population groups including migrants, people living with HIV, and people living with TB.
Thanks to a multiyear strategy supported by LHSS and predecessor USAID projects, Vietnam now funds approximately 52 percent of its HIV/AIDS program through domestic financial resources.
2022 marked Vietnam's 10-year journey to sustain its HIV response with domestic financing (2013 – 2022). The country now stands out as a global example for sustainability and domestic resource mobilization for its HIV program.
Vietnam is one of the 30 countries with the highest burden of TB and drug-resistant TB in the world, with more than 172,000 cases and 10,400 deaths from TB in Vietnam in 2020 (WHO). On July 1, TB treatment facilities nationwide started providing TB drugs to patients through social health insurance, marking an important milestone for financial sustainability.
This report presents findings from LHSS Vietnam's international review of diagnosis-related group contracts and provides a series of evaluations and recommendations.
This rapid assessment aimed to determine which health facilities in seven high-TB burden provinces of Vietnam meet social health insurance (SHI) requirements for TB service provision and for reimbursement of TB services through the SHI scheme.
This report provides a review of international experience to draw out practical and scientific approaches for both the Ministry of Health (MOH) and Vietnam Social Security (VSS) to consider. Conclusions and recommendations are provided.
Lhss prepared this report, discussing procurement and payment considerations related to the transition of first-line tuberculosis (TB) drug procurement in Vietnam from the central state budget to the social health insurance fund starting in 2022.
Conducted by LHSS, this market analysis examines four factors affecting SHI-covered ARV procurement and supply in Vietnam, and it also summarizes findings and recommendations across each of these factors.
This document provides a roadmap for Vietnam’s National Tuberculosis (TB) Program to transition procurement and payment for TB drugs to the country’s social health insurance scheme.
This report summarizes the results of a review of international experience and best practices related to pro-health excise taxes.
LHSS in this report recommends that the government raise pro-health excise taxes at greater rates than currently proposed by the Ministry of Finance in order to increase the revenue raised.
For the first time, Vietnam has procured TB medicines using its national social health insurance scheme.